237 related articles for article (PubMed ID: 33297850)
21. Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.
Hadipour Moghaddam SP; Yazdimamaghani M; Ghandehari H
J Control Release; 2018 Jul; 282():62-75. PubMed ID: 29679666
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles.
Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M
J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840
[TBL] [Abstract][Full Text] [Related]
23. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery.
Yuan X; Peng S; Lin W; Wang J; Zhang L
J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647
[TBL] [Abstract][Full Text] [Related]
24. Hollow Mesoporous Silica@Metal-Organic Framework and Applications for pH-Responsive Drug Delivery.
Jia X; Yang Z; Wang Y; Chen Y; Yuan H; Chen H; Xu X; Gao X; Liang Z; Sun Y; Li JR; Zheng H; Cao R
ChemMedChem; 2018 Mar; 13(5):400-405. PubMed ID: 29337422
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
Hu X; Wang Y; Peng B
Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
[TBL] [Abstract][Full Text] [Related]
26. pH-Sensitive drug delivery system based on modified dextrin coated mesoporous silica nanoparticles.
Chen H; Zheng D; Liu J; Kuang Y; Li Q; Zhang M; Ye H; Qin H; Xu Y; Li C; Jiang B
Int J Biol Macromol; 2016 Apr; 85():596-603. PubMed ID: 26776872
[TBL] [Abstract][Full Text] [Related]
27. Dendrimer-like mesoporous silica nanospheres with suitable surface functionality to combat the multidrug resistance.
Xu W; Gao X; Ge P; Jiang F; Zhang X; Xie J
Int J Pharm; 2018 Dec; 553(1-2):349-362. PubMed ID: 30393166
[TBL] [Abstract][Full Text] [Related]
28. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
[TBL] [Abstract][Full Text] [Related]
29. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
30. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
31. A multifunctional biphasic suspension of mesoporous silica encapsulated with YVO4:Eu3+ and Fe3O4 nanoparticles: synergistic effect towards cancer therapy and imaging.
Shanta Singh N; Kulkarni H; Pradhan L; Bahadur D
Nanotechnology; 2013 Feb; 24(6):065101. PubMed ID: 23324398
[TBL] [Abstract][Full Text] [Related]
32. pH/GSH-Dual-Sensitive Hollow Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Cancer Therapy.
Chen Z; Wan L; Yuan Y; Kuang Y; Xu X; Liao T; Liu J; Xu ZQ; Jiang B; Li C
ACS Biomater Sci Eng; 2020 Jun; 6(6):3375-3387. PubMed ID: 33463161
[TBL] [Abstract][Full Text] [Related]
33. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.
Li D; Huang X; Wu Y; Li J; Cheng W; He J; Tian H; Huang Y
Biomater Sci; 2016 Feb; 4(2):272-80. PubMed ID: 26484364
[TBL] [Abstract][Full Text] [Related]
34. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
Li Z; Zhang Y; Feng N
Expert Opin Drug Deliv; 2019 Mar; 16(3):219-237. PubMed ID: 30686075
[TBL] [Abstract][Full Text] [Related]
35. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of poly (acrylic acid) modified mesoporous silica nanoparticles as pH response carrier for β-elemene self-micro emulsifying.
Yan B; Wang Y; Ma Y; Zhao J; Liu Y; Wang L
Int J Pharm; 2019 Dec; 572():118768. PubMed ID: 31669556
[TBL] [Abstract][Full Text] [Related]
37. Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite.
Hao X; Hu X; Zhang C; Chen S; Li Z; Yang X; Liu H; Jia G; Liu D; Ge K; Liang XJ; Zhang J
ACS Nano; 2015 Oct; 9(10):9614-25. PubMed ID: 26316321
[TBL] [Abstract][Full Text] [Related]
38. Dual-responsive mesoporous silica nanoparticles coated with carbon dots and polymers for drug encapsulation and delivery.
Li X; Hu S; Lin Z; Yi J; Liu X; Tang X; Wu Q; Zhang G
Nanomedicine (Lond); 2020 Oct; 15(25):2447-2458. PubMed ID: 32945224
[No Abstract] [Full Text] [Related]
39. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
40. An optimized mesoporous silica nanosphere-based carrier system with chemically removable Au nanoparticle caps for redox-stimulated and targeted drug delivery.
Zhang L; Wei F; Al-Ammari A; Sun D
Nanotechnology; 2020 Nov; 31(47):475102. PubMed ID: 32413886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
